NEW DELHI: The Central Drugs Standard Control Organization (CDSCO) has launched an investigation into the four cough and cold syrups in question after the World Health Organization (WHO) on Wednesday issued an alert about them being "potentially linked with acute kidney injuries and 66 deaths among children in Gambia."
WHO announced on Wednesday that it has issued a medical product warning for four tainted medications that had been found in the Gambia and may have caused 66 infant deaths and acute renal damage.
"The four medicines are syrups for colds and coughs made by the Indian company Maiden Pharmaceuticals Limited. WHO is conducting additional research with the business and regulatory bodies in India," WHO had added further.
"The CDSCO has taken up the matter and ordered a detailed investigation against the cough and cold syrups made and exported to The Gambia by Maiden Pharmaceuticals Limited," said a source.
The source claims that CDSCO has been asked to receive the report on the determination of a causal relationship between the issue of medicinal products and death as soon as possible from the global health organisation.
The CDSCO and the State Drugs Controller, Haryana, have initiated a thorough inquiry to learn the truth about the drugs in question. Maiden Pharmaceuticals Limited is situated in Sonepat, Haryana.
However, preliminary research has shown that Maiden Pharmaceutical Limited is a producer authorised to produce the items in question by the State Drug Controller and has a manufacturing permit.
The WHO stated that even though the tainted goods have only been found in The Gambia so far, they may have been exported to other nations. WHO advised all nations to identify and halt the sale of these products in order to protect patients from further harm.
Study finds mRNA boosters extend Covid protection but it eventually wanes
How setting a sleep schedule Help Teenagers Get More Sleep
